Mathers James 4
4 · BIOLIFE SOLUTIONS INC · Filed Feb 6, 2020
Insider Transaction Report
Form 4
Mathers James
Vice President of Sales
Transactions
- Sale
Common Stock
2020-02-04$14.03/sh−2,113$29,645→ 17,384 total - Exercise/Conversion
Common Stock
2020-02-04$1.64/sh+2,113$3,465→ 19,497 total - Exercise/Conversion
Employee Stock Option
2020-02-04−2,113→ 0 totalExercise: $1.64From: 2019-03-01Exp: 2021-12-20→ Common Stock (2,113 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.03, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The reporting person's Form 4 filed on January 23, 2019 reported a remainder of 2,613 derivative securities when in fact the remainder was 2,113 derivative securities beneficially owned by the reporting person.